CATH Superfamily 2.60.200.40
The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was: waiting to be named.
FunFam 10: Sphingosine kinase 1
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 31 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
D-erythro-sphingosine kinase activity GO:0017050
Catalysis of the reaction: sphingosine + ATP = sphingosine 1-phosphate + ADP.
|
8 | Q8CI15 (/IDA) Q91V26 (/IDA) Q9JIA7 (/IDA) Q9JIA7 (/IDA) Q9NRA0 (/IDA) Q9NRA0 (/IDA) Q9NYA1 (/IDA) Q9NYA1 (/IDA) |
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
7 | Q91V26 (/IPI) Q9JIA7 (/IPI) Q9JIA7 (/IPI) Q9NRA0 (/IPI) Q9NRA0 (/IPI) Q9NYA1 (/IPI) Q9NYA1 (/IPI) |
Sphinganine kinase activity GO:0008481
Catalysis of the reaction: ATP + sphinganine = ADP + sphinganine 1-phosphate.
|
5 | Q8CI15 (/IDA) Q9NRA0 (/IDA) Q9NRA0 (/IDA) Q9NYA1 (/IDA) Q9NYA1 (/IDA) |
Magnesium ion binding GO:0000287
Interacting selectively and non-covalently with magnesium (Mg) ions.
|
4 | Q8CI15 (/ISS) Q91V26 (/ISS) Q96HV8 (/ISS) Q9N0A5 (/ISS) |
Sphinganine kinase activity GO:0008481
Catalysis of the reaction: ATP + sphinganine = ADP + sphinganine 1-phosphate.
|
4 | Q8CI15 (/ISS) Q91V26 (/ISS) Q9JIA7 (/ISS) Q9JIA7 (/ISS) |
Sphinganine kinase activity GO:0008481
Catalysis of the reaction: ATP + sphinganine = ADP + sphinganine 1-phosphate.
|
4 | Q9JIA7 (/NAS) Q9JIA7 (/NAS) Q9NRA0 (/NAS) Q9NRA0 (/NAS) |
D-erythro-sphingosine kinase activity GO:0017050
Catalysis of the reaction: sphingosine + ATP = sphingosine 1-phosphate + ADP.
|
4 | Q8CI15 (/ISS) Q91V26 (/ISS) Q96HV8 (/ISS) Q9N0A5 (/ISS) |
Sphingosine-1-phosphate receptor activity GO:0038036
Combining with the sphingolipid sphingosine-1-phosphate (S1P), and transmitting the signal across the membrane by activating an associated G-protein.
|
4 | Q9NRA0 (/IMP) Q9NRA0 (/IMP) Q9NYA1 (/IMP) Q9NYA1 (/IMP) |
Sphinganine kinase activity GO:0008481
Catalysis of the reaction: ATP + sphinganine = ADP + sphinganine 1-phosphate.
|
3 | Q8CI15 (/ISO) Q9JIA7 (/ISO) Q9JIA7 (/ISO) |
Acetyltransferase activity GO:0016407
Catalysis of the transfer of an acetyl group to an acceptor molecule.
|
3 | Q91V26 (/ISS) Q9NYA1 (/ISS) Q9NYA1 (/ISS) |
D-erythro-sphingosine kinase activity GO:0017050
Catalysis of the reaction: sphingosine + ATP = sphingosine 1-phosphate + ADP.
|
3 | Q8CI15 (/ISO) Q9JIA7 (/ISO) Q9JIA7 (/ISO) |
Sphingosine-1-phosphate receptor activity GO:0038036
Combining with the sphingolipid sphingosine-1-phosphate (S1P), and transmitting the signal across the membrane by activating an associated G-protein.
|
3 | Q8CI15 (/ISO) Q9JIA7 (/ISO) Q9JIA7 (/ISO) |
Magnesium ion binding GO:0000287
Interacting selectively and non-covalently with magnesium (Mg) ions.
|
2 | Q9NYA1 (/IDA) Q9NYA1 (/IDA) |
DNA binding GO:0003677
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
|
2 | Q9NYA1 (/IDA) Q9NYA1 (/IDA) |
Calmodulin binding GO:0005516
Interacting selectively and non-covalently with calmodulin, a calcium-binding protein with many roles, both in the calcium-bound and calcium-free states.
|
2 | Q9NYA1 (/IDA) Q9NYA1 (/IDA) |
ATP binding GO:0005524
Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
|
2 | Q9NYA1 (/IDA) Q9NYA1 (/IDA) |
Lipid binding GO:0008289
Interacting selectively and non-covalently with a lipid.
|
2 | Q9NYA1 (/IDA) Q9NYA1 (/IDA) |
Lipid binding GO:0008289
Interacting selectively and non-covalently with a lipid.
|
2 | Q8CI15 (/ISS) Q91V26 (/ISS) |
Ras GTPase binding GO:0017016
Interacting selectively and non-covalently with any member of the Ras superfamily of monomeric GTPases.
|
2 | Q9NRA0 (/NAS) Q9NRA0 (/NAS) |
D-erythro-sphingosine kinase activity GO:0017050
Catalysis of the reaction: sphingosine + ATP = sphingosine 1-phosphate + ADP.
|
2 | Q9JIA7 (/IMP) Q9JIA7 (/IMP) |
D-erythro-sphingosine kinase activity GO:0017050
Catalysis of the reaction: sphingosine + ATP = sphingosine 1-phosphate + ADP.
|
2 | Q9NYA1 (/TAS) Q9NYA1 (/TAS) |
Nucleosomal histone binding GO:0031493
Interacting selectively and non-covalently with a histone that is assembled into a nucleosome.
|
2 | Q9NRA0 (/IDA) Q9NRA0 (/IDA) |
Nucleosomal histone binding GO:0031493
Interacting selectively and non-covalently with a histone that is assembled into a nucleosome.
|
2 | Q9JIA7 (/ISO) Q9JIA7 (/ISO) |
Protein phosphatase 2A binding GO:0051721
Interacting selectively and non-covalently with the enzyme protein phosphatase 2A.
|
2 | Q9NYA1 (/IPI) Q9NYA1 (/IPI) |
Magnesium ion binding GO:0000287
Interacting selectively and non-covalently with magnesium (Mg) ions.
|
1 | Q8CI15 (/ISO) |
DNA binding GO:0003677
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
|
1 | Q8CI15 (/ISO) |
Calmodulin binding GO:0005516
Interacting selectively and non-covalently with calmodulin, a calcium-binding protein with many roles, both in the calcium-bound and calcium-free states.
|
1 | Q8CI15 (/ISO) |
ATP binding GO:0005524
Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
|
1 | Q8CI15 (/ISO) |
Lipid binding GO:0008289
Interacting selectively and non-covalently with a lipid.
|
1 | Q8CI15 (/ISO) |
Acetyltransferase activity GO:0016407
Catalysis of the transfer of an acetyl group to an acceptor molecule.
|
1 | Q8CI15 (/IMP) |
Protein phosphatase 2A binding GO:0051721
Interacting selectively and non-covalently with the enzyme protein phosphatase 2A.
|
1 | Q8CI15 (/ISO) |
There are 164 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Sphinganine-1-phosphate biosynthetic process GO:0006669
The chemical reactions and pathways resulting in the formation of sphinganine-1-phosphate, the phosphorylated derivative of D-erythro-2-amino-1,3-octadecanediol.
|
4 | Q9JIA7 (/IDA) Q9JIA7 (/IDA) Q9NRA0 (/IDA) Q9NRA0 (/IDA) |
Sphinganine-1-phosphate biosynthetic process GO:0006669
The chemical reactions and pathways resulting in the formation of sphinganine-1-phosphate, the phosphorylated derivative of D-erythro-2-amino-1,3-octadecanediol.
|
4 | Q9JIA7 (/NAS) Q9JIA7 (/NAS) Q9NRA0 (/NAS) Q9NRA0 (/NAS) |
Sphingosine metabolic process GO:0006670
The chemical reactions and pathways involving sphingosine (sphing-4-enine), trans-D-erytho-2-amino-octadec-4-ene-1,3-diol, a long chain amino diol sphingoid base that occurs in most sphingolipids in animal tissues.
|
4 | Q8CI15 (/ISS) Q91V26 (/ISS) Q9NRA0 (/ISS) Q9NRA0 (/ISS) |
Cell population proliferation GO:0008283
The multiplication or reproduction of cells, resulting in the expansion of a cell population.
|
4 | Q9JIA7 (/NAS) Q9JIA7 (/NAS) Q9NRA0 (/NAS) Q9NRA0 (/NAS) |
Sphingolipid biosynthetic process GO:0030148
The chemical reactions and pathways resulting in the formation of sphingolipids, any of a class of lipids containing the long-chain amine diol sphingosine or a closely related base (a sphingoid).
|
4 | Q9NRA0 (/TAS) Q9NRA0 (/TAS) Q9NYA1 (/TAS) Q9NYA1 (/TAS) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
4 | Q9JIA7 (/IDA) Q9JIA7 (/IDA) Q9NRA0 (/IDA) Q9NRA0 (/IDA) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
4 | Q9JIA7 (/NAS) Q9JIA7 (/NAS) Q9NRA0 (/NAS) Q9NRA0 (/NAS) |
Sphingosine biosynthetic process GO:0046512
The chemical reactions and pathways resulting in the formation of sphingosine (sphing-4-enine), trans-D-erytho-2-amino-octadec-4-ene-1,3-diol, a long chain amino diol sphingoid base that occurs in most sphingolipids in animal tissues.
|
4 | Q9NRA0 (/IGI) Q9NRA0 (/IGI) Q9NYA1 (/IGI) Q9NYA1 (/IGI) |
Sphingosine biosynthetic process GO:0046512
The chemical reactions and pathways resulting in the formation of sphingosine (sphing-4-enine), trans-D-erytho-2-amino-octadec-4-ene-1,3-diol, a long chain amino diol sphingoid base that occurs in most sphingolipids in animal tissues.
|
4 | Q9NRA0 (/IMP) Q9NRA0 (/IMP) Q9NYA1 (/IMP) Q9NYA1 (/IMP) |
Positive regulation of NF-kappaB transcription factor activity GO:0051092
Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB.
|
4 | Q8CI15 (/ISS) Q91V26 (/ISS) Q9NYA1 (/ISS) Q9NYA1 (/ISS) |
Regulation of neuroinflammatory response GO:0150077
Any process that modulates the frequency, rate or extent of neuroinflammatory response.
|
4 | Q8CI15 (/ISS) Q91V26 (/ISS) Q9NYA1 (/ISS) Q9NYA1 (/ISS) |
Regulation of cytochrome-c oxidase activity GO:1904959
Any process that modulates the frequency, rate or extent of cytochrome-c oxidase activity.
|
4 | Q9JIA7 (/IMP) Q9JIA7 (/IMP) Q9NRA0 (/IMP) Q9NRA0 (/IMP) |
Positive regulation of ceramide biosynthetic process GO:2000304
Any process that activates or increases the frequency, rate or extent of ceramide biosynthetic process.
|
4 | Q9JIA7 (/IDA) Q9JIA7 (/IDA) Q9NRA0 (/IDA) Q9NRA0 (/IDA) |
Blood vessel development GO:0001568
The process whose specific outcome is the progression of a blood vessel over time, from its formation to the mature structure. The blood vessel is the vasculature carrying blood.
|
3 | Q8CI15 (/IGI) Q9JIA7 (/IGI) Q9JIA7 (/IGI) |
Protein acetylation GO:0006473
The addition of an acetyl group to a protein amino acid. An acetyl group is CH3CO-, derived from acetic
|
3 | Q91V26 (/ISS) Q9NYA1 (/ISS) Q9NYA1 (/ISS) |
Brain development GO:0007420
The process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.).
|
3 | Q8CI15 (/IGI) Q9JIA7 (/IGI) Q9JIA7 (/IGI) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
3 | Q8CI15 (/IGI) Q9JIA7 (/IGI) Q9JIA7 (/IGI) |
Positive regulation of interleukin-17 production GO:0032740
Any process that activates or increases the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines.
|
3 | Q8CI15 (/ISS) Q9NYA1 (/ISS) Q9NYA1 (/ISS) |
Cellular response to vascular endothelial growth factor stimulus GO:0035924
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vascular endothelial growth factor stimulus.
|
3 | Q8CI15 (/IDA) Q9NYA1 (/IDA) Q9NYA1 (/IDA) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
3 | Q8CI15 (/IDA) Q9NYA1 (/IDA) Q9NYA1 (/IDA) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
3 | Q91V26 (/IMP) Q9NYA1 (/IMP) Q9NYA1 (/IMP) |
Sphingosine biosynthetic process GO:0046512
The chemical reactions and pathways resulting in the formation of sphingosine (sphing-4-enine), trans-D-erytho-2-amino-octadec-4-ene-1,3-diol, a long chain amino diol sphingoid base that occurs in most sphingolipids in animal tissues.
|
3 | Q8CI15 (/ISO) Q9JIA7 (/ISO) Q9JIA7 (/ISO) |
Regulation of phagocytosis GO:0050764
Any process that modulates the frequency, rate or extent of phagocytosis, the process in which phagocytes engulf external particulate material.
|
3 | Q91V26 (/ISS) Q9NYA1 (/ISS) Q9NYA1 (/ISS) |
Positive regulation of NF-kappaB transcription factor activity GO:0051092
Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB.
|
3 | Q91V26 (/IMP) Q9NYA1 (/IMP) Q9NYA1 (/IMP) |
Regulation of microglial cell activation GO:1903978
Any process that modulates the frequency, rate or extent of microglial cell activation.
|
3 | Q91V26 (/ISS) Q9NYA1 (/ISS) Q9NYA1 (/ISS) |
Regulation of endosomal vesicle fusion GO:1905364
Any process that modulates the frequency, rate or extent of endosomal vesicle fusion.
|
3 | Q91V26 (/ISS) Q9NYA1 (/ISS) Q9NYA1 (/ISS) |
Cytokine secretion involved in immune response GO:0002374
The regulated release of cytokines from a cell that contributes to an immune response.
|
2 | Q9JIA7 (/IMP) Q9JIA7 (/IMP) |
Cytokine secretion involved in immune response GO:0002374
The regulated release of cytokines from a cell that contributes to an immune response.
|
2 | Q9NRA0 (/ISS) Q9NRA0 (/ISS) |
Protein folding GO:0006457
The process of assisting in the covalent and noncovalent assembly of single chain polypeptides or multisubunit complexes into the correct tertiary structure.
|
2 | Q9NYA1 (/TAS) Q9NYA1 (/TAS) |
Sphinganine-1-phosphate biosynthetic process GO:0006669
The chemical reactions and pathways resulting in the formation of sphinganine-1-phosphate, the phosphorylated derivative of D-erythro-2-amino-1,3-octadecanediol.
|
2 | Q9JIA7 (/ISO) Q9JIA7 (/ISO) |
Sphinganine-1-phosphate biosynthetic process GO:0006669
The chemical reactions and pathways resulting in the formation of sphinganine-1-phosphate, the phosphorylated derivative of D-erythro-2-amino-1,3-octadecanediol.
|
2 | Q9JIA7 (/ISS) Q9JIA7 (/ISS) |
Sphingosine metabolic process GO:0006670
The chemical reactions and pathways involving sphingosine (sphing-4-enine), trans-D-erytho-2-amino-octadec-4-ene-1,3-diol, a long chain amino diol sphingoid base that occurs in most sphingolipids in animal tissues.
|
2 | Q9NYA1 (/IDA) Q9NYA1 (/IDA) |
Sphingosine metabolic process GO:0006670
The chemical reactions and pathways involving sphingosine (sphing-4-enine), trans-D-erytho-2-amino-octadec-4-ene-1,3-diol, a long chain amino diol sphingoid base that occurs in most sphingolipids in animal tissues.
|
2 | Q9JIA7 (/IMP) Q9JIA7 (/IMP) |
Sphingosine metabolic process GO:0006670
The chemical reactions and pathways involving sphingosine (sphing-4-enine), trans-D-erytho-2-amino-octadec-4-ene-1,3-diol, a long chain amino diol sphingoid base that occurs in most sphingolipids in animal tissues.
|
2 | Q9NYA1 (/TAS) Q9NYA1 (/TAS) |
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
|
2 | Q9NYA1 (/TAS) Q9NYA1 (/TAS) |
Female pregnancy GO:0007565
The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth.
|
2 | Q6AYB2 (/IEP) Q91V26 (/IEP) |
Positive regulation of peptidyl-threonine phosphorylation GO:0010800
Any process that increases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
|
2 | Q9NYA1 (/IMP) Q9NYA1 (/IMP) |
Regulation of tumor necrosis factor-mediated signaling pathway GO:0010803
Any process that modulates the rate or extent of the tumor necrosis factor-mediated signaling pathway. The tumor necrosis factor-mediated signaling pathway is the series of molecular signals generated as a consequence of tumor necrosis factor binding to a cell surface receptor.
|
2 | Q9NYA1 (/IDA) Q9NYA1 (/IDA) |
Regulation of tumor necrosis factor-mediated signaling pathway GO:0010803
Any process that modulates the rate or extent of the tumor necrosis factor-mediated signaling pathway. The tumor necrosis factor-mediated signaling pathway is the series of molecular signals generated as a consequence of tumor necrosis factor binding to a cell surface receptor.
|
2 | Q8CI15 (/ISS) Q91V26 (/ISS) |
Calcium-mediated signaling GO:0019722
Any intracellular signal transduction in which the signal is passed on within the cell via calcium ions.
|
2 | Q9NYA1 (/IDA) Q9NYA1 (/IDA) |
Regulation of endocytosis GO:0030100
Any process that modulates the frequency, rate or extent of endocytosis.
|
2 | Q9NYA1 (/IDA) Q9NYA1 (/IDA) |
Regulation of endocytosis GO:0030100
Any process that modulates the frequency, rate or extent of endocytosis.
|
2 | Q8CI15 (/ISS) Q91V26 (/ISS) |
Positive regulation of cell growth GO:0030307
Any process that activates or increases the frequency, rate, extent or direction of cell growth.
|
2 | Q9NYA1 (/IDA) Q9NYA1 (/IDA) |
Negative regulation of cell growth GO:0030308
Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth.
|
2 | Q9JIA7 (/IDA) Q9JIA7 (/IDA) |
Negative regulation of cell growth GO:0030308
Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth.
|
2 | Q9NRA0 (/ISS) Q9NRA0 (/ISS) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
2 | Q9NYA1 (/IDA) Q9NYA1 (/IDA) |
Negative regulation of histone deacetylation GO:0031064
Any process that stops, prevents, or reduces the frequency, rate or extent of the removal of acetyl groups from histones.
|
2 | Q9NRA0 (/IDA) Q9NRA0 (/IDA) |
Negative regulation of histone deacetylation GO:0031064
Any process that stops, prevents, or reduces the frequency, rate or extent of the removal of acetyl groups from histones.
|
2 | Q9JIA7 (/ISO) Q9JIA7 (/ISO) |
Negative regulation of histone deacetylation GO:0031064
Any process that stops, prevents, or reduces the frequency, rate or extent of the removal of acetyl groups from histones.
|
2 | Q9JIA7 (/ISS) Q9JIA7 (/ISS) |
Positive regulation of protein ubiquitination GO:0031398
Any process that activates or increases the frequency, rate or extent of the addition of ubiquitin groups to a protein.
|
2 | Q9NYA1 (/IDA) Q9NYA1 (/IDA) |
Positive regulation of protein ubiquitination GO:0031398
Any process that activates or increases the frequency, rate or extent of the addition of ubiquitin groups to a protein.
|
2 | Q8CI15 (/ISS) Q91V26 (/ISS) |
Positive regulation of mast cell activation involved in immune response GO:0033008
Any process that activates or increases the frequency, rate, or extent of mast cell activation as part of an immune response.
|
2 | Q9JIA7 (/IMP) Q9JIA7 (/IMP) |
Positive regulation of mast cell activation involved in immune response GO:0033008
Any process that activates or increases the frequency, rate, or extent of mast cell activation as part of an immune response.
|
2 | Q9NRA0 (/ISS) Q9NRA0 (/ISS) |
Response to tumor necrosis factor GO:0034612
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus.
|
2 | Q9NYA1 (/IDA) Q9NYA1 (/IDA) |
Response to tumor necrosis factor GO:0034612
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus.
|
2 | Q8CI15 (/ISS) Q91V26 (/ISS) |
Intracellular signal transduction GO:0035556
The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.
|
2 | Q9NYA1 (/TAS) Q9NYA1 (/TAS) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
2 | Q9JIA7 (/ISO) Q9JIA7 (/ISO) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
2 | Q9NYA1 (/TAS) Q9NYA1 (/TAS) |
Regulation of I-kappaB kinase/NF-kappaB signaling GO:0043122
Any process that modulates I-kappaB kinase/NF-kappaB signaling.
|
2 | Q9JIA7 (/IMP) Q9JIA7 (/IMP) |
Regulation of I-kappaB kinase/NF-kappaB signaling GO:0043122
Any process that modulates I-kappaB kinase/NF-kappaB signaling.
|
2 | Q9NRA0 (/ISS) Q9NRA0 (/ISS) |
Positive regulation of mast cell degranulation GO:0043306
Any process that activates or increases the frequency, rate or extent of mast cell degranulation.
|
2 | Q9JIA7 (/IMP) Q9JIA7 (/IMP) |
Positive regulation of mast cell degranulation GO:0043306
Any process that activates or increases the frequency, rate or extent of mast cell degranulation.
|
2 | Q9NRA0 (/ISS) Q9NRA0 (/ISS) |
Histone H2A-K5 acetylation GO:0043977
The modification of histone H2A by the addition of an acetyl group to a lysine residue at position 5 of the histone.
|
2 | Q9NRA0 (/IDA) Q9NRA0 (/IDA) |
Histone H2A-K5 acetylation GO:0043977
The modification of histone H2A by the addition of an acetyl group to a lysine residue at position 5 of the histone.
|
2 | Q9JIA7 (/ISO) Q9JIA7 (/ISO) |
Histone H2A-K5 acetylation GO:0043977
The modification of histone H2A by the addition of an acetyl group to a lysine residue at position 5 of the histone.
|
2 | Q9JIA7 (/ISS) Q9JIA7 (/ISS) |
Histone H2B-K12 acetylation GO:0043980
The modification of histone H2B by the addition of an acetyl group to a lysine residue at position 12 of the histone.
|
2 | Q9NRA0 (/IDA) Q9NRA0 (/IDA) |
Histone H2B-K12 acetylation GO:0043980
The modification of histone H2B by the addition of an acetyl group to a lysine residue at position 12 of the histone.
|
2 | Q9JIA7 (/ISO) Q9JIA7 (/ISO) |
Histone H2B-K12 acetylation GO:0043980
The modification of histone H2B by the addition of an acetyl group to a lysine residue at position 12 of the histone.
|
2 | Q9JIA7 (/ISS) Q9JIA7 (/ISS) |
Positive regulation of angiogenesis GO:0045766
Any process that activates or increases angiogenesis.
|
2 | Q9NYA1 (/IDA) Q9NYA1 (/IDA) |
Positive regulation of gene expression, epigenetic GO:0045815
Any epigenetic process that activates or increases the rate of gene expression.
|
2 | Q9NRA0 (/IDA) Q9NRA0 (/IDA) |
Positive regulation of gene expression, epigenetic GO:0045815
Any epigenetic process that activates or increases the rate of gene expression.
|
2 | Q9JIA7 (/ISO) Q9JIA7 (/ISO) |
Positive regulation of gene expression, epigenetic GO:0045815
Any epigenetic process that activates or increases the rate of gene expression.
|
2 | Q9JIA7 (/ISS) Q9JIA7 (/ISS) |
Positive regulation of mitotic cell cycle GO:0045931
Any process that activates or increases the rate or extent of progression through the mitotic cell cycle.
|
2 | Q9NYA1 (/IDA) Q9NYA1 (/IDA) |
Positive regulation of smooth muscle contraction GO:0045987
Any process that activates or increases the frequency, rate or extent of smooth muscle contraction.
|
2 | Q9NYA1 (/IDA) Q9NYA1 (/IDA) |
Sphingoid catabolic process GO:0046521
The chemical reactions and pathways resulting in the breakdown of sphingoids, any of a class of compounds comprising sphinganine and its homologues and stereoisomers, and derivatives of these compounds.
|
2 | Q9NYA1 (/NAS) Q9NYA1 (/NAS) |
Positive regulation of fibroblast proliferation GO:0048146
Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells.
|
2 | Q9NYA1 (/IDA) Q9NYA1 (/IDA) |
Interleukin-6 secretion GO:0072604
The regulated release of interleukin-6 from a cell.
|
2 | Q9JIA7 (/IMP) Q9JIA7 (/IMP) |
Interleukin-6 secretion GO:0072604
The regulated release of interleukin-6 from a cell.
|
2 | Q9NRA0 (/ISS) Q9NRA0 (/ISS) |
Interleukin-13 secretion GO:0072611
The regulated release of interleukin-13 from a cell.
|
2 | Q9JIA7 (/IMP) Q9JIA7 (/IMP) |
Interleukin-13 secretion GO:0072611
The regulated release of interleukin-13 from a cell.
|
2 | Q9NRA0 (/ISS) Q9NRA0 (/ISS) |
Positive regulation of protein kinase C signaling GO:0090037
Any process that increases the frequency, rate, or extent of a series of reactions, mediated by the intracellular serine/threonine kinase protein kinase C, which occurs as a result of a single trigger reaction or compound.
|
2 | Q9JIA7 (/IMP) Q9JIA7 (/IMP) |
Positive regulation of protein kinase C signaling GO:0090037
Any process that increases the frequency, rate, or extent of a series of reactions, mediated by the intracellular serine/threonine kinase protein kinase C, which occurs as a result of a single trigger reaction or compound.
|
2 | Q9NRA0 (/ISS) Q9NRA0 (/ISS) |
Positive regulation of calcium ion import GO:0090280
Any process that increases the rate, frequency, or extent of the directed movement of calcium ions into a cell or organelle.
|
2 | Q9JIA7 (/IMP) Q9JIA7 (/IMP) |
Positive regulation of calcium ion import GO:0090280
Any process that increases the rate, frequency, or extent of the directed movement of calcium ions into a cell or organelle.
|
2 | Q9NRA0 (/ISS) Q9NRA0 (/ISS) |
Regulation of neuroinflammatory response GO:0150077
Any process that modulates the frequency, rate or extent of neuroinflammatory response.
|
2 | Q8CI15 (/IMP) Q91V26 (/IMP) |
Negative regulation of ceramide biosynthetic process GO:1900060
Any process that stops, prevents or reduces the frequency, rate or extent of a ceramide biosynthetic process.
|
2 | Q9NYA1 (/IDA) Q9NYA1 (/IDA) |
Positive regulation of p38MAPK cascade GO:1900745
Any process that activates or increases the frequency, rate or extent of p38MAPK cascade.
|
2 | Q9NYA1 (/IDA) Q9NYA1 (/IDA) |
Positive regulation of p38MAPK cascade GO:1900745
Any process that activates or increases the frequency, rate or extent of p38MAPK cascade.
|
2 | Q8CI15 (/ISS) Q91V26 (/ISS) |
Positive regulation of NIK/NF-kappaB signaling GO:1901224
Any process that activates or increases the frequency, rate or extent of NIK/NF-kappaB signaling.
|
2 | Q9NYA1 (/IMP) Q9NYA1 (/IMP) |
Positive regulation of NIK/NF-kappaB signaling GO:1901224
Any process that activates or increases the frequency, rate or extent of NIK/NF-kappaB signaling.
|
2 | Q8CI15 (/ISS) Q91V26 (/ISS) |
Negative regulation of histone deacetylase activity GO:1901726
Any process that stops, prevents or reduces the frequency, rate or extent of histone deacetylase activity.
|
2 | Q9NRA0 (/IDA) Q9NRA0 (/IDA) |
Negative regulation of histone deacetylase activity GO:1901726
Any process that stops, prevents or reduces the frequency, rate or extent of histone deacetylase activity.
|
2 | Q9JIA7 (/ISO) Q9JIA7 (/ISO) |
Negative regulation of histone deacetylase activity GO:1901726
Any process that stops, prevents or reduces the frequency, rate or extent of histone deacetylase activity.
|
2 | Q9JIA7 (/ISS) Q9JIA7 (/ISS) |
Regulation of reactive oxygen species biosynthetic process GO:1903426
Any process that modulates the frequency, rate or extent of reactive oxygen species biosynthetic process.
|
2 | Q9JIA7 (/IMP) Q9JIA7 (/IMP) |
Regulation of reactive oxygen species biosynthetic process GO:1903426
Any process that modulates the frequency, rate or extent of reactive oxygen species biosynthetic process.
|
2 | Q9NRA0 (/ISS) Q9NRA0 (/ISS) |
Cellular response to phorbol 13-acetate 12-myristate GO:1904628
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a phorbol 13-acetate 12-myristate stimulus.
|
2 | Q9NRA0 (/IDA) Q9NRA0 (/IDA) |
Cellular response to phorbol 13-acetate 12-myristate GO:1904628
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a phorbol 13-acetate 12-myristate stimulus.
|
2 | Q9JIA7 (/ISO) Q9JIA7 (/ISO) |
Cellular response to phorbol 13-acetate 12-myristate GO:1904628
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a phorbol 13-acetate 12-myristate stimulus.
|
2 | Q9JIA7 (/ISS) Q9JIA7 (/ISS) |
Regulation of cytochrome-c oxidase activity GO:1904959
Any process that modulates the frequency, rate or extent of cytochrome-c oxidase activity.
|
2 | Q9JIA7 (/ISO) Q9JIA7 (/ISO) |
Tumor necrosis factor secretion GO:1990774
The regulated release of tumor necrosis factor from a cell. Tumor necrosis factor is an inflammatory cytokine produced by macrophages/monocytes during acute inflammation and which is responsible for a diverse range of signaling events within cells, leading to necrosis or apoptosis.
|
2 | Q9JIA7 (/IMP) Q9JIA7 (/IMP) |
Tumor necrosis factor secretion GO:1990774
The regulated release of tumor necrosis factor from a cell. Tumor necrosis factor is an inflammatory cytokine produced by macrophages/monocytes during acute inflammation and which is responsible for a diverse range of signaling events within cells, leading to necrosis or apoptosis.
|
2 | Q9NRA0 (/ISS) Q9NRA0 (/ISS) |
Positive regulation of ceramide biosynthetic process GO:2000304
Any process that activates or increases the frequency, rate or extent of ceramide biosynthetic process.
|
2 | Q9JIA7 (/ISO) Q9JIA7 (/ISO) |
Positive regulation of histone H3-K9 acetylation GO:2000617
Any process that activates or increases the frequency, rate or extent of histone H3-K9 acetylation.
|
2 | Q9NRA0 (/IDA) Q9NRA0 (/IDA) |
Positive regulation of histone H3-K9 acetylation GO:2000617
Any process that activates or increases the frequency, rate or extent of histone H3-K9 acetylation.
|
2 | Q9JIA7 (/ISO) Q9JIA7 (/ISO) |
Positive regulation of histone H3-K9 acetylation GO:2000617
Any process that activates or increases the frequency, rate or extent of histone H3-K9 acetylation.
|
2 | Q9JIA7 (/ISS) Q9JIA7 (/ISS) |
Regulation of ATP biosynthetic process GO:2001169
Any process that modulates the frequency, rate or extent of ATP biosynthetic process.
|
2 | Q9JIA7 (/IMP) Q9JIA7 (/IMP) |
Regulation of ATP biosynthetic process GO:2001169
Any process that modulates the frequency, rate or extent of ATP biosynthetic process.
|
2 | Q9NRA0 (/ISS) Q9NRA0 (/ISS) |
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
|
1 | Q91V26 (/IMP) |
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
|
1 | Q8CI15 (/ISO) |
Positive regulation of neurotransmitter secretion GO:0001956
Any process that activates or increases the frequency, rate or extent of the regulated release of a neurotransmitter.
|
1 | Q91V26 (/IMP) |
Positive regulation of neurotransmitter secretion GO:0001956
Any process that activates or increases the frequency, rate or extent of the regulated release of a neurotransmitter.
|
1 | Q8CI15 (/ISO) |
Protein acetylation GO:0006473
The addition of an acetyl group to a protein amino acid. An acetyl group is CH3CO-, derived from acetic
|
1 | Q8CI15 (/IMP) |
Sphingosine metabolic process GO:0006670
The chemical reactions and pathways involving sphingosine (sphing-4-enine), trans-D-erytho-2-amino-octadec-4-ene-1,3-diol, a long chain amino diol sphingoid base that occurs in most sphingolipids in animal tissues.
|
1 | Q8CI15 (/ISO) |
Inflammatory response GO:0006954
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
|
1 | Q8CI15 (/IMP) |
Cellular response to starvation GO:0009267
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of nourishment.
|
1 | Q91V26 (/IEP) |
Positive regulation of peptidyl-threonine phosphorylation GO:0010800
Any process that increases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
|
1 | Q8CI15 (/ISO) |
Regulation of tumor necrosis factor-mediated signaling pathway GO:0010803
Any process that modulates the rate or extent of the tumor necrosis factor-mediated signaling pathway. The tumor necrosis factor-mediated signaling pathway is the series of molecular signals generated as a consequence of tumor necrosis factor binding to a cell surface receptor.
|
1 | Q91V26 (/IMP) |
Regulation of tumor necrosis factor-mediated signaling pathway GO:0010803
Any process that modulates the rate or extent of the tumor necrosis factor-mediated signaling pathway. The tumor necrosis factor-mediated signaling pathway is the series of molecular signals generated as a consequence of tumor necrosis factor binding to a cell surface receptor.
|
1 | Q8CI15 (/ISO) |
Positive regulation of neuron projection development GO:0010976
Any process that increases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
|
1 | Q91V26 (/IMP) |
Positive regulation of neuron projection development GO:0010976
Any process that increases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
|
1 | Q8CI15 (/ISO) |
Response to organic cyclic compound GO:0014070
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
|
1 | Q91V26 (/IEP) |
Response to amine GO:0014075
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amine stimulus. An amine is a compound formally derived from ammonia by replacing one, two or three hydrogen atoms by hydrocarbyl groups.
|
1 | Q91V26 (/IEP) |
Phosphorylation GO:0016310
The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
|
1 | Q8CI15 (/IDA) |
Cyclooxygenase pathway GO:0019371
The chemical reactions and pathways by which prostaglandins are formed from arachidonic acid, and in which prostaglandin-endoperoxide synthase (cyclooxygenase) catalyzes the committed step in the conversion of arachidonic acid to the prostaglandin-endoperoxides PGG2 and PGH2.
|
1 | Q91V26 (/IDA) |
Cyclooxygenase pathway GO:0019371
The chemical reactions and pathways by which prostaglandins are formed from arachidonic acid, and in which prostaglandin-endoperoxide synthase (cyclooxygenase) catalyzes the committed step in the conversion of arachidonic acid to the prostaglandin-endoperoxides PGG2 and PGH2.
|
1 | Q8CI15 (/ISO) |
Calcium-mediated signaling GO:0019722
Any intracellular signal transduction in which the signal is passed on within the cell via calcium ions.
|
1 | Q8CI15 (/ISO) |
Regulation of endocytosis GO:0030100
Any process that modulates the frequency, rate or extent of endocytosis.
|
1 | Q8CI15 (/IMP) |
Regulation of endocytosis GO:0030100
Any process that modulates the frequency, rate or extent of endocytosis.
|
1 | Q8CI15 (/ISO) |
Positive regulation of cell growth GO:0030307
Any process that activates or increases the frequency, rate, extent or direction of cell growth.
|
1 | Q8CI15 (/ISO) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
1 | Q91V26 (/IMP) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
1 | Q8CI15 (/ISO) |
Positive regulation of protein ubiquitination GO:0031398
Any process that activates or increases the frequency, rate or extent of the addition of ubiquitin groups to a protein.
|
1 | Q8CI15 (/ISO) |
Response to magnesium ion GO:0032026
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a magnesium ion stimulus.
|
1 | Q91V26 (/IEP) |
Response to progesterone GO:0032570
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a progesterone stimulus.
|
1 | Q91V26 (/IEP) |
Regulation of interleukin-1 beta production GO:0032651
Any process that modulates the frequency, rate, or extent of interleukin-1 beta production.
|
1 | Q8CI15 (/IMP) |
Positive regulation of interleukin-17 production GO:0032740
Any process that activates or increases the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines.
|
1 | Q91V26 (/IMP) |
Positive regulation of interleukin-17 production GO:0032740
Any process that activates or increases the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines.
|
1 | Q8CI15 (/ISO) |
Response to ATP GO:0033198
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ATP (adenosine 5'-triphosphate) stimulus.
|
1 | Q91V26 (/IEP) |
Response to tumor necrosis factor GO:0034612
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus.
|
1 | Q8CI15 (/ISO) |
Cellular response to vascular endothelial growth factor stimulus GO:0035924
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vascular endothelial growth factor stimulus.
|
1 | Q8CI15 (/ISO) |
Cellular response to vascular endothelial growth factor stimulus GO:0035924
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vascular endothelial growth factor stimulus.
|
1 | Q91V26 (/ISS) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
1 | Q8CI15 (/ISO) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
1 | Q91V26 (/ISS) |
Positive regulation of angiogenesis GO:0045766
Any process that activates or increases angiogenesis.
|
1 | Q8CI15 (/ISO) |
Positive regulation of mitotic nuclear division GO:0045840
Any process that activates or increases the frequency, rate or extent of mitosis.
|
1 | Q8CI15 (/IGI) |
Positive regulation of mitotic cell cycle GO:0045931
Any process that activates or increases the rate or extent of progression through the mitotic cell cycle.
|
1 | Q8CI15 (/ISO) |
Positive regulation of smooth muscle contraction GO:0045987
Any process that activates or increases the frequency, rate or extent of smooth muscle contraction.
|
1 | Q8CI15 (/ISO) |
Positive regulation of fibroblast proliferation GO:0048146
Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells.
|
1 | Q8CI15 (/ISO) |
Regulation of phagocytosis GO:0050764
Any process that modulates the frequency, rate or extent of phagocytosis, the process in which phagocytes engulf external particulate material.
|
1 | Q8CI15 (/IMP) |
Positive regulation of NF-kappaB transcription factor activity GO:0051092
Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB.
|
1 | Q8CI15 (/ISO) |
Cellular response to hydrogen peroxide GO:0070301
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.
|
1 | Q8CI15 (/IDA) |
Cellular response to hydrogen peroxide GO:0070301
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.
|
1 | Q91V26 (/IEP) |
Response to interleukin-1 GO:0070555
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus.
|
1 | Q91V26 (/IEP) |
Cellular response to growth factor stimulus GO:0071363
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth factor stimulus.
|
1 | Q91V26 (/IEP) |
DNA biosynthetic process GO:0071897
The cellular DNA metabolic process resulting in the formation of DNA, deoxyribonucleic acid, one of the two main types of nucleic acid, consisting of a long unbranched macromolecule formed from one or two strands of linked deoxyribonucleotides, the 3'-phosphate group of each constituent deoxyribonucleotide being joined in 3',5'-phosphodiester linkage to the 5'-hydroxyl group of the deoxyribose moiety of the next one.
|
1 | Q8CI15 (/IMP) |
Sphingolipid mediated signaling pathway GO:0090520
A series of molecular signals mediated by a sphingolipid.
|
1 | Q8CI15 (/IDA) |
Regulation of neuroinflammatory response GO:0150077
Any process that modulates the frequency, rate or extent of neuroinflammatory response.
|
1 | Q8CI15 (/ISO) |
Negative regulation of ceramide biosynthetic process GO:1900060
Any process that stops, prevents or reduces the frequency, rate or extent of a ceramide biosynthetic process.
|
1 | Q8CI15 (/IMP) |
Negative regulation of ceramide biosynthetic process GO:1900060
Any process that stops, prevents or reduces the frequency, rate or extent of a ceramide biosynthetic process.
|
1 | Q8CI15 (/ISO) |
Negative regulation of ceramide biosynthetic process GO:1900060
Any process that stops, prevents or reduces the frequency, rate or extent of a ceramide biosynthetic process.
|
1 | Q91V26 (/ISS) |
Positive regulation of p38MAPK cascade GO:1900745
Any process that activates or increases the frequency, rate or extent of p38MAPK cascade.
|
1 | Q8CI15 (/ISO) |
Positive regulation of NIK/NF-kappaB signaling GO:1901224
Any process that activates or increases the frequency, rate or extent of NIK/NF-kappaB signaling.
|
1 | Q8CI15 (/ISO) |
Regulation of microglial cell activation GO:1903978
Any process that modulates the frequency, rate or extent of microglial cell activation.
|
1 | Q8CI15 (/IMP) |
Regulation of endosomal vesicle fusion GO:1905364
Any process that modulates the frequency, rate or extent of endosomal vesicle fusion.
|
1 | Q8CI15 (/IMP) |
There are 42 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
9 | Q53ZR5 (/IDA) Q53ZR5 (/IDA) Q91V26 (/IDA) Q9JIA7 (/IDA) Q9JIA7 (/IDA) Q9NRA0 (/IDA) Q9NRA0 (/IDA) Q9NYA1 (/IDA) Q9NYA1 (/IDA) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
7 | Q8CI15 (/IDA) Q9JIA7 (/IDA) Q9JIA7 (/IDA) Q9NRA0 (/IDA) Q9NRA0 (/IDA) Q9NYA1 (/IDA) Q9NYA1 (/IDA) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
5 | Q8CI15 (/IDA) Q9JIA7 (/IDA) Q9JIA7 (/IDA) Q9NRA0 (/IDA) Q9NRA0 (/IDA) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
5 | Q91V26 (/ISS) Q9JIA7 (/ISS) Q9JIA7 (/ISS) Q9NYA1 (/ISS) Q9NYA1 (/ISS) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
5 | Q53ZR5 (/IDA) Q53ZR5 (/IDA) Q91V26 (/IDA) Q9NYA1 (/IDA) Q9NYA1 (/IDA) |
Intracellular membrane-bounded organelle GO:0043231
Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
|
5 | A0A024QZH5 (/IDA) A0A024QZH5 (/IDA) M0R344 (/IDA) Q9NRA0 (/IDA) Q9NRA0 (/IDA) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
4 | Q9NRA0 (/TAS) Q9NRA0 (/TAS) Q9NYA1 (/TAS) Q9NYA1 (/TAS) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
4 | Q9JIA7 (/IDA) Q9JIA7 (/IDA) Q9NRA0 (/IDA) Q9NRA0 (/IDA) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
3 | Q8CI15 (/ISO) Q9JIA7 (/ISO) Q9JIA7 (/ISO) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
3 | Q8CI15 (/ISO) Q9JIA7 (/ISO) Q9JIA7 (/ISO) |
Endocytic vesicle GO:0030139
A membrane-bounded intracellular vesicle formed by invagination of the plasma membrane around an extracellular substance. Endocytic vesicles fuse with early endosomes to deliver the cargo for further sorting.
|
3 | Q91V26 (/ISS) Q9NYA1 (/ISS) Q9NYA1 (/ISS) |
Nucleosome GO:0000786
A complex comprised of DNA wound around a multisubunit core and associated proteins, which forms the primary packing unit of DNA into higher order structures.
|
2 | Q9NRA0 (/IDA) Q9NRA0 (/IDA) |
Nucleosome GO:0000786
A complex comprised of DNA wound around a multisubunit core and associated proteins, which forms the primary packing unit of DNA into higher order structures.
|
2 | Q9JIA7 (/ISO) Q9JIA7 (/ISO) |
Nucleosome GO:0000786
A complex comprised of DNA wound around a multisubunit core and associated proteins, which forms the primary packing unit of DNA into higher order structures.
|
2 | Q9JIA7 (/ISS) Q9JIA7 (/ISS) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
2 | Q9JIA7 (/ISO) Q9JIA7 (/ISO) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
2 | Q8CI15 (/ISS) Q91V26 (/ISS) |
Mitochondrion GO:0005739
A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
|
2 | Q9JIA7 (/IDA) Q9JIA7 (/IDA) |
Mitochondrion GO:0005739
A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
|
2 | Q9NRA0 (/ISS) Q9NRA0 (/ISS) |
Mitochondrial inner membrane GO:0005743
The inner, i.e. lumen-facing, lipid bilayer of the mitochondrial envelope. It is highly folded to form cristae.
|
2 | Q9JIA7 (/IDA) Q9JIA7 (/IDA) |
Lysosomal membrane GO:0005765
The lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm.
|
2 | Q9NRA0 (/HDA) Q9NRA0 (/HDA) |
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
|
2 | Q9JIA7 (/IDA) Q9JIA7 (/IDA) |
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
|
2 | Q9NRA0 (/ISS) Q9NRA0 (/ISS) |
Clathrin-coated pit GO:0005905
A part of the endomembrane system in the form of an invagination of a membrane upon which a clathrin coat forms, and that can be converted by vesicle budding into a clathrin-coated vesicle. Coated pits form on the plasma membrane, where they are involved in receptor-mediated selective transport of many proteins and other macromolecules across the cell membrane, in the trans-Golgi network, and on some endosomes.
|
2 | Q9NYA1 (/IDA) Q9NYA1 (/IDA) |
Clathrin-coated pit GO:0005905
A part of the endomembrane system in the form of an invagination of a membrane upon which a clathrin coat forms, and that can be converted by vesicle budding into a clathrin-coated vesicle. Coated pits form on the plasma membrane, where they are involved in receptor-mediated selective transport of many proteins and other macromolecules across the cell membrane, in the trans-Golgi network, and on some endosomes.
|
2 | Q8CI15 (/ISS) Q91V26 (/ISS) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
2 | Q9JIA7 (/ISO) Q9JIA7 (/ISO) |
Early endosome membrane GO:0031901
The lipid bilayer surrounding an early endosome.
|
2 | Q9NYA1 (/IDA) Q9NYA1 (/IDA) |
Early endosome membrane GO:0031901
The lipid bilayer surrounding an early endosome.
|
2 | Q8CI15 (/ISS) Q91V26 (/ISS) |
Intracellular membrane-bounded organelle GO:0043231
Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
|
2 | Q9JIA7 (/ISO) Q9JIA7 (/ISO) |
Presynapse GO:0098793
The part of a synapse that is part of the presynaptic cell.
|
2 | Q9NYA1 (/ISS) Q9NYA1 (/ISS) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
1 | Q8CI15 (/IMP) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
1 | Q8CI15 (/ISO) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
1 | Q8CI15 (/ISS) |
Clathrin-coated pit GO:0005905
A part of the endomembrane system in the form of an invagination of a membrane upon which a clathrin coat forms, and that can be converted by vesicle budding into a clathrin-coated vesicle. Coated pits form on the plasma membrane, where they are involved in receptor-mediated selective transport of many proteins and other macromolecules across the cell membrane, in the trans-Golgi network, and on some endosomes.
|
1 | Q8CI15 (/ISO) |
Synaptic vesicle GO:0008021
A secretory organelle, typically 50 nm in diameter, of presynaptic nerve terminals; accumulates in high concentrations of neurotransmitters and secretes these into the synaptic cleft by fusion with the 'active zone' of the presynaptic plasma membrane.
|
1 | Q91V26 (/IDA) |
Synaptic vesicle GO:0008021
A secretory organelle, typically 50 nm in diameter, of presynaptic nerve terminals; accumulates in high concentrations of neurotransmitters and secretes these into the synaptic cleft by fusion with the 'active zone' of the presynaptic plasma membrane.
|
1 | Q8CI15 (/ISO) |
Endocytic vesicle GO:0030139
A membrane-bounded intracellular vesicle formed by invagination of the plasma membrane around an extracellular substance. Endocytic vesicles fuse with early endosomes to deliver the cargo for further sorting.
|
1 | Q8CI15 (/IDA) |
Axon GO:0030424
The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter.
|
1 | Q91V26 (/IDA) |
Axon GO:0030424
The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter.
|
1 | Q8CI15 (/ISO) |
Early endosome membrane GO:0031901
The lipid bilayer surrounding an early endosome.
|
1 | Q8CI15 (/ISO) |
Neuron projection GO:0043005
A prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
|
1 | Q91V26 (/IDA) |
Neuron projection GO:0043005
A prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
|
1 | Q8CI15 (/ISO) |
Presynapse GO:0098793
The part of a synapse that is part of the presynaptic cell.
|
1 | Q8CI15 (/IDA) |